908 Devices (NASDAQ:MASS) Receives "Sell (E+)" Rating from Weiss Ratings

Weiss Ratings reissued their sell (e+) rating on shares of 908 Devices (NASDAQ:MASS - Free Report) in a research note published on Saturday,Weiss Ratings reports.

Separately, Stephens reaffirmed an "overweight" rating and set a $6.00 target price on shares of 908 Devices in a research note on Wednesday, January 15th. Two analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, 908 Devices has a consensus rating of "Moderate Buy" and a consensus target price of $5.33.

908 Devices Stock Down 5.1 %

NASDAQ:MASS traded down $0.22 on Friday, hitting $4.03. The stock had a trading volume of 450,774 shares, compared to its average volume of 937,220. 908 Devices has a 1-year low of $1.81 and a 1-year high of $7.56. The stock has a market cap of $142.20 million, a price-to-earnings ratio of -2.27 and a beta of 0.99. The company has a fifty day moving average price of $2.96 and a two-hundred day moving average price of $2.93.

Institutional Investors Weigh In On 908 Devices

A number of institutional investors and hedge funds have recently modified their holdings of the company. Two Sigma Advisers LP acquired a new stake in 908 Devices in the fourth quarter valued at $30,000. Prudential Financial Inc. acquired a new position in 908 Devices during the fourth quarter worth approximately $34,000. Occudo Quantitative Strategies LP purchased a new position in 908 Devices during the fourth quarter worth approximately $36,000. Two Sigma Investments LP purchased a new stake in shares of 908 Devices during the 4th quarter valued at $42,000. Finally, B. Riley Wealth Advisors Inc. acquired a new stake in 908 Devices during the 3rd quarter worth approximately $45,000. Institutional investors and hedge funds own 88.06% of the company's stock.

Remove Ads

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.